the role of icis in the adjuvant setting for rcc
Published 1 year ago • 54 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
0:35
the latest developments in adjuvant therapy for rcc
-
1:03
potential of adjuvant therapy for rcc
-
2:35
adjuvant therapy in rcc: harnessing prognostic information
-
0:50
emerging role of adjuvant immunotherapy in oncology
-
5:56
recent data in the adjuvant setting of rcc
-
0:43
what's on the horizon for adjuvant therapies for rcc?
-
1:08
clinical trials in adjuvant rcc
-
0:39
phase i/ii study of adapt-001 plus an ici for patients with immune refractory cancers
-
11:18
first-line icis in advanced non-clear cell rcc
-
5:54
adjuvant sunitinib’s role in the treatment of rcc
-
2:11
dr. haas on adjuvant sorafenib or sunitinib for rcc
-
7:18
vegf tki therapy in the adjuvant setting of rcc
-
4:49
unmet needs in the adjuvant setting for renal cell carcinoma
-
2:32
adjuvant therapy in rcc - dr. andre fay (english version)
-
3:04
kidney cancer: minimizing toxicities and hassle in adjuvant therapy
-
3:47
other clinical trials in renal cell carcinoma
-
1:29
phase i/ii study of nivolumab and axitinib for advanced rcc
-
32:22
auau podcast: adjuvant therapy in renal cell carcinoma
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale